Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
928.8 DKK
-0.92%
Market Closed
Updated:
May 26, 2024
Novo Nordisk A/S
Depreciation & Amortization
|
Novo Nordisk A/S
Depreciation & Amortization Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Depreciation & Amortization
kr10.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
12%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Depreciation & Amortization
kr2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Depreciation & Amortization
kr245m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Depreciation & Amortization?
Depreciation & Amortization
10.6B
DKK
10.6B
DKK
Based on the financial report for Mar 31, 2024, Novo Nordisk A/S's Depreciation & Amortization amounts to 10.6B DKK.
What is Novo Nordisk A/S's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
12%
12%
Over the last year, the Depreciation & Amortization growth was 43%. The average annual Depreciation & Amortization growth rates for Novo Nordisk A/S have been 21% over the past three years , 20% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
